noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Arrowhead Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)
Uber Technologies Inc.

Amendment to Statement of Changes in Beneficial Ownership (Form 4/A)
United States Attorney's Office[...]

Salisbury Methamphetamine Distributor Sentenced to 10 Years in Prison

Healthcare

Citius Pharmaceuticals Inc.

04/24/2026 | Press release | Distributed by Public on 04/24/2026 15:00

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At- The-Market Under Nasdaq Rules (Form 8-K)

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Citius Pharmaceuticals Inc. published this content on April 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 24, 2026 at 21:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]